Holen Sie sich die Stockscreener-App
16.52
0.63%
-0.076
Schlusskurs vom Vortag:
$16.60
Offen:
$16.67
24-Stunden-Volumen:
99,700
Relative Volume:
0.36
Marktkapitalisierung:
$569.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.03%
1M Leistung:
+10.85%
6M Leistung:
-40.13%
1J Leistung:
+0.00%
1-Tages-Spanne:
$16.26
$17.23
1-Wochen-Bereich:
$15.55
$17.93
52-Wochen-Spanne:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Vergleichen Sie CBLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
16.55 | 569.98M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
128.75 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.03 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
386.32 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.35 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.95 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
Ceribell stock holds $36 target amid US-China trade deal hopes - Investing.com Canada
US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results - Yahoo Finance
Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - The Globe and Mail
AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail
Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks
CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer
MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World
Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com
Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks
CeriBell Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% By Investing.com - Investing.com South Africa
Ceribell reports Q1 EPS (36c), consensus (46c) - TipRanks
Ceribell Reports First Quarter 2025 Financial Results - GlobeNewswire
CeriBell Inc (CBLL) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World
Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing
41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times
CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq
CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com
Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times
Ceribell Receives FedRAMP® High Authorization, Expanding - GlobeNewswire
Ceribell announces EEG system received full RedRAMP High authorization - TipRanks
JPMorgan Chase & Co. Takes $880,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Geode Capital Management LLC Makes New $6.65 Million Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
CeriBell, Inc. to Release Q1 2025 Financial Results and Host Conference Call on May 8, 2025 - Nasdaq
CBLL Stock Sees Surge of Approximately 3.50% in Last Five Days - knoxdaily.com
Ceribell Inc (CBLL) stock analysis: A comprehensive overview - uspostnews.com
CeriBell (NASDAQ:CBLL) Trading Down 2.9% on Insider Selling - Defense World
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 - MSN
Alliancebernstein L.P. Invests $532,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell wins FDA nod for algorithm to detect pediatric seizures - MedTech Dive
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating - TipRanks
Vanguard Group Inc. Takes $18.02 Million Position in CeriBell (NASDAQ:CBLL) - Defense World
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm - MSN
Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm - TipRanks
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm - marketscreener.com
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Es liegen keine Finanzdaten für Ceribell Inc (CBLL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Ceribell Inc-Aktie (CBLL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Apr 22 '25 |
Sale |
15.06 |
300 |
4,518 |
742,779 |
2.11%
1.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):